USD 1.07
(5.54%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 | 4.12 Billion JPY | 50.19% |
2023 | 2.93 Billion JPY | 26.0% |
2022 | 2.33 Billion JPY | 17.55% |
2021 | 1.98 Billion JPY | -15.18% |
2020 | 2.33 Billion JPY | 13.66% |
2019 | 2.05 Billion JPY | 10.35% |
2018 | 1.86 Billion JPY | -17.19% |
2017 | 2.25 Billion JPY | 4.41% |
2016 | 2.15 Billion JPY | 5.81% |
2015 | 2.03 Billion JPY | 49.32% |
2014 | 1.36 Billion JPY | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q4 | 1.31 Billion JPY | 70.63% |
2024 FY | 3.76 Billion JPY | 28.16% |
2024 Q3 | 773 Million JPY | -51.32% |
2024 Q1 | 874 Million JPY | 23.8% |
2024 Q2 | 1.58 Billion JPY | 81.69% |
2023 Q3 | 800 Million JPY | 4.85% |
2023 FY | 2.93 Billion JPY | 26.0% |
2023 Q1 | 664 Million JPY | -4.73% |
2023 Q2 | 763 Million JPY | 14.91% |
2023 Q4 | 706 Million JPY | -11.75% |
2022 Q4 | 697 Million JPY | 30.04% |
2022 Q3 | 536 Million JPY | -0.56% |
2022 Q2 | 539 Million JPY | -3.75% |
2022 FY | 2.33 Billion JPY | 17.55% |
2022 Q1 | 560 Million JPY | -10.83% |
2021 Q2 | 433 Million JPY | -10.17% |
2021 FY | 1.98 Billion JPY | -15.18% |
2021 Q3 | 442 Million JPY | 2.08% |
2021 Q4 | 628 Million JPY | 42.08% |
2021 Q1 | 482 Million JPY | -45.1% |
2020 Q3 | 486 Million JPY | -5.63% |
2020 FY | 2.33 Billion JPY | 13.66% |
2020 Q1 | 459 Million JPY | -42.12% |
2020 Q4 | 878 Million JPY | 80.66% |
2020 Q2 | 515 Million JPY | 12.2% |
2019 FY | 2.05 Billion JPY | 10.35% |
2019 Q2 | 364 Million JPY | -16.7% |
2019 Q4 | 793 Million JPY | 70.17% |
2019 Q3 | 466 Million JPY | 28.02% |
2019 Q1 | 437 Million JPY | 95.32% |
2018 Q4 | 223.73 Million JPY | -38.87% |
2018 FY | 1.86 Billion JPY | -17.19% |
2018 Q1 | 552.49 Million JPY | -8.02% |
2018 Q2 | 400 Million JPY | -27.6% |
2018 Q3 | 366 Million JPY | -8.5% |
2017 Q2 | 541.3 Million JPY | 0.35% |
2017 FY | 2.25 Billion JPY | 4.41% |
2017 Q1 | 539.39 Million JPY | -21.81% |
2017 Q3 | 569.68 Million JPY | 5.24% |
2017 Q4 | 600.68 Million JPY | 5.44% |
2016 Q4 | 689.81 Million JPY | 19.86% |
2016 FY | 2.15 Billion JPY | 5.81% |
2016 Q3 | 575.53 Million JPY | 23.13% |
2016 Q2 | 467.4 Million JPY | 10.46% |
2016 Q1 | 423.16 Million JPY | -45.16% |
2015 Q4 | 771.56 Million JPY | 59.07% |
2015 Q3 | 485.04 Million JPY | 11.05% |
2015 Q2 | 436.78 Million JPY | 26.9% |
2015 Q1 | 344.19 Million JPY | -42.03% |
2015 FY | 2.03 Billion JPY | 49.32% |
2014 FY | 1.36 Billion JPY | 0.0% |
2014 Q4 | 593.79 Million JPY | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
IR-Med Inc. | 4.89 Million USD | -84268.615% |
CVR Medical Corp. | - USD | -Infinity% |
BioElectronics Corporation | 740.67 Thousand USD | -557363.722% |
Medical Supply International USA, Inc. | 1.32 Million USD | -312585.536% |
Polarean Imaging plc | 12.24 Million USD | -33626.882% |
Avitar, Inc. | 3.56 Million USD | -115574.043% |
AVITA Medical, Inc. | 80.77 Million USD | -5011.463% |
Manhattan Scientifics, Inc. | 703 Thousand USD | -587239.972% |
Össur hf. | 396.18 Million USD | -942.187% |
Zecotek Photonics Inc. | 3.46 Million USD | -119185.408% |
QHSLab, Inc. | 961.65 Thousand USD | -429264.854% |
Wellstar International, Inc. | 1.79 Million USD | -229966.819% |
Össur hf. | 396.18 Million USD | -942.187% |
Bionovate Technologies Corp | - USD | -Infinity% |
EKF Diagnostics Holdings plc | 21.77 Million USD | -18859.5% |
Escalon Medical Corp. | 5.25 Million USD | -78537.613% |
Aurora Spine Corporation | 8.65 Million USD | -47592.818% |
BrainsWay Ltd. | 28.01 Million USD | -14636.955% |
Lattice Biologics Ltd. | - USD | -Infinity% |
NewCardio, Inc. | 9.56 Million USD | -43070.778% |
Hamilton Thorne Ltd. | 33.57 Million USD | -12198.732% |
Vivos Inc. | 2.78 Million USD | -148046.288% |
MicroPort Scientific Corporation | 1.04 Billion USD | -293.889% |
Kelyniam Global, Inc. | 2.27 Million USD | -181375.042% |
REMSleep Holdings, Inc. | 1.01 Million USD | -406736.91% |
CYduct Diagnostics, Inc. | 435.5 Thousand USD | -948005.626% |
Nanomix Corporation | 8.36 Million USD | -49244.444% |
Theraclion SA | 7.43 Million USD | -55398.565% |
Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
Wellness Center USA, Inc. | 1.29 Million USD | -318845.633% |
Positron Corporation | 1 Million USD | -409813.778% |
Rafina Innovations Inc. | - USD | -Infinity% |
Electromedical Technologies, Inc. | 3.11 Million USD | -132646.236% |
Lombard Medical, Inc. | 30.29 Million USD | -13531.562% |
ALR Technologies Inc. | 6.33 Million USD | -65067.339% |
Stratec SE | 46.32 Million USD | -8814.003% |
Vycor Medical, Inc. | 1.27 Million USD | -323625.58% |
Heart Tronics, Inc. | 14.46 Million USD | -28454.468% |
Nu-Med Plus, Inc. | 120.52 Thousand USD | -3425716.836% |
Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -2000200.36% |
SANUWAVE Health, Inc. | 14.15 Million USD | -29078.15% |
VMS Rehab Systems, Inc. | 63.63 USD | -6489077379.176% |
Guided Therapeutics, Inc. | 3.49 Million USD | -118107.844% |
Ingen Technologies, Inc. | 1.88 Million USD | -219268.501% |
Odyssey Group International, Inc. | -14.26 Million USD | 29052.937% |
United American Healthcare Corporation | 59 Thousand USD | -6998205.085% |
ECGI Holdings, Inc. | 407.48 Thousand USD | -1013188.833% |
Capital Group Holdings, Inc. | 634.68 Thousand USD | -650455.864% |
ADM Tronics Unlimited, Inc. | 1.69 Million USD | -243417.648% |
Urologix, Inc. | 10.09 Million USD | -40813.595% |
Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | -326733.859% |
Nexeon MedSystems Inc. | 5.94 Million USD | -69314.767% |
SS Innovations International, Inc. | 21.38 Million USD | -19210.798% |
Qualis Innovations, Inc. | 230.24 Thousand USD | -1793238.285% |
Smith & Nephew plc | 3.46 Billion USD | -19.094% |
NIOX Group Plc | 22.27 Million USD | -18434.396% |
Fuse Medical, Inc. | 10.35 Million USD | -39793.662% |
Broncus Holding Corporation | 38.15 Million USD | -10722.77% |
Brain Scientific Inc. | 9.66 Million USD | -42631.186% |
Pressure BioSciences, Inc. | 10.3 Million USD | -39976.017% |
Health Logic Interactive Inc. | 60.69 Thousand USD | -6802430.561% |